INS and diabetes mellitus: At the time of joining the one-year intervention, the median duration (interquartile range) of diabetes was 4.3 (1.3–8.8) years and most participants (84.3%) were on glucose-lowering medication [including oral hypoglycemic agents (OHAs) or insulin or both].